Deferred Tax Assets, Valuation Allowance of IGC Pharma, Inc. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
IGC Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
  • IGC Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $19,124,000, a 28% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $19,124,000 +$4,147,000 +28% 31 Mar 2025 10-K 27 Jun 2025 2025 FY
Q1 2024 $14,977,000 +$1,404,000 +10% 31 Mar 2024 10-K 27 Jun 2025 2025 FY
Q1 2023 $13,573,000 +$3,003,000 +28% 31 Mar 2023 10-K 24 Jun 2024 2024 FY
Q1 2022 $10,570,000 +$3,488,000 +49% 31 Mar 2022 10-K 07 Jul 2023 2023 FY
Q1 2021 $7,082,000 +$1,939,000 +38% 31 Mar 2021 10-K 23 Jun 2022 2022 FY
Q1 2020 $5,143,000 +$4,385,000 +578% 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q1 2019 $758,000 +$181,000 +31% 31 Mar 2019 10-K 13 Jul 2020 2020 FY
Q1 2018 $577,000 -$75,283 -12% 31 Mar 2018 10-K 14 Jun 2019 2019 FY
Q1 2017 $652,283 -$639,461 -50% 31 Mar 2017 10-K 21 Jun 2018 2018 FY
Q1 2016 $1,291,744 -$440,625 -25% 31 Mar 2016 10-K 14 Jul 2017 2017 FY
Q1 2015 $1,732,369 +$646,302 +60% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q1 2014 $1,086,067 +$1,977,883 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q1 2013 $891,816 +$1,825,753 +67% 31 Mar 2013 10-K 16 Jul 2013 2012 FY
Q1 2012 $2,717,569 31 Mar 2012 10-K 16 Jul 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.